{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:41:56Z","timestamp":1707525716238},"reference-count":54,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,17]]},"DOI":"10.7759\/cureus.52430","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T12:34:15Z","timestamp":1705494855000},"source":"Crossref","is-referenced-by-count":0,"title":["Patient-Reported Outcomes in Pleural Effusions: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Eleanor K","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219784","article-title":"British Thoracic Society Guideline for pleural disease","volume":"78","author":"Roberts ME","year":"2023","unstructured":"Roberts ME, Rahman NM, Maskell NA, et al.. British Thoracic Society Guideline for pleural disease. Thorax. 2023, 78:s1-s42. 10.1136\/thorax-2022-219784","journal-title":"Thorax"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s13665-016-0130-3","article-title":"Measurement of breathlessness in patients with malignant pleural effusions","volume":"5","author":"Mishra EK","year":"2016","unstructured":"Mishra EK. Measurement of breathlessness in patients with malignant pleural effusions. Curr Pulmonol Rep. 2016, 5:1-6. 10.1007\/s13665-016-0130-3","journal-title":"Curr Pulmonol Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2020-002584","article-title":"Therapeutic thoracentesis symptoms and activity: a qualitative study","volume":"13","author":"Twose C","year":"2023","unstructured":"Twose C, Ferris R, Wilson A, Rahman N, Farquhar M, Mishra E. Therapeutic thoracentesis symptoms and activity: a qualitative study. BMJ Support Palliat Care. 2023, 13:e190-6. 10.1136\/bmjspcare-2020-002584","journal-title":"BMJ Support Palliat Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123798","article-title":"Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions","volume":"10","author":"Mishra EK","year":"2015","unstructured":"Mishra EK, Corcoran JP, Hallifax RJ, Stradling J, Maskell NA, Rahman NM. Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions. PLoS One. 2015, 10:e0123798. 10.1371\/journal.pone.0123798","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3721-9","article-title":"Feasibility of objectively measured physical activity and sedentary behavior in patients with malignant pleural effusion","volume":"25","author":"Jeffery E","year":"2017","unstructured":"Jeffery E, Lee YG, McVeigh J, Straker L, Wooding T, Newton RU, Peddle-McIntyre C. Feasibility of objectively measured physical activity and sedentary behavior in patients with malignant pleural effusion. Support Care Cancer. 2017, 25:3133-41. 10.1007\/s00520-017-3721-9","journal-title":"Support Care Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0000000000000933","article-title":"Measurement properties of the Brief Pain Inventory-Short Form (BPI-SF) and Revised Short McGill Pain Questionnaire Version-2 (SF-MPQ-2) in pain-related musculoskeletal conditions: a systematic review","volume":"37","author":"Jumbo SU","year":"2021","unstructured":"Jumbo SU, MacDermid JC, Kalu ME, Packham TL, Athwal GS, Faber KJ. Measurement properties of the Brief Pain Inventory-Short Form (BPI-SF) and Revised Short McGill Pain Questionnaire Version-2 (SF-MPQ-2) in pain-related musculoskeletal conditions: a systematic review. Clin J Pain. 2021, 37:454-74. 10.1097\/AJP.0000000000000933","journal-title":"Clin J Pain"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.118521","article-title":"Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12","volume":"65","author":"Yorke J","year":"2010","unstructured":"Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12. Thorax. 2010, 65:21-6. 10.1136\/thx.2009.118521","journal-title":"Thorax"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/thx.48.1.33","article-title":"Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation","volume":"48","author":"Mak VH","year":"1993","unstructured":"Mak VH, Bugler JR, Roberts CM, Spiro SG. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax. 1993, 48:33-8. 10.1136\/thx.48.1.33","journal-title":"Thorax"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00353-2","article-title":"Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial","volume":"10","author":"Psallidas I","year":"2022","unstructured":"Psallidas I, Hassan M, Yousuf A, et al.. Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial. Lancet Respir Med. 2022, 10:139-48. 10.1016\/S2213-2600(21)00353-2","journal-title":"Lancet Respir Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202111-1301OC","article-title":"Silver nitrate-coated versus standard indwelling pleural catheter for malignant effusions: the SWIFT randomized trial","volume":"19","author":"Shrager JB","year":"2022","unstructured":"Shrager JB, Bhatnagar R, Kearney CT, et al.. Silver nitrate-coated versus standard indwelling pleural catheter for malignant effusions: the SWIFT randomized trial. Ann Am Thorac Soc. 2022, 19:1722-9. 10.1513\/AnnalsATS.202111-1301OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01362-2021","article-title":"Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions","volume":"59","author":"Walker SP","year":"2022","unstructured":"Walker SP, Bintcliffe O, Keenan E, et al.. Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions. Eur Respir J. 2022, 59:2101362. 10.1183\/13993003.01362-2021","journal-title":"Eur Respir J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024758","article-title":"The clinical efficacy of external application of mirabilite and rhubarb combined with intrathoracic chemotherapy in treating malignant pleural effusion: a prospective, randomized, controlled clinical trial","volume":"100","author":"Zhang H","year":"2021","unstructured":"Zhang H, Jiang M, Gao L, Lin Z. The clinical efficacy of external application of mirabilite and rhubarb combined with intrathoracic chemotherapy in treating malignant pleural effusion: a prospective, randomized, controlled clinical trial. Medicine (Baltimore). 2021, 100:e24758. 10.1097\/MD.0000000000024758","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.19997","article-title":"Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial","volume":"323","author":"Bhatnagar R","year":"2020","unstructured":"Bhatnagar R, Piotrowska HE, Laskawiec-Szkonter M, et al.. Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial. JAMA. 2020, 323:60-9. 10.1001\/jama.2019.19997","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ejcdt.ejcdt_63_19","article-title":"Comparison between thoracoscopic pleurodesis results by talc, doxycycline poudrage, and silver nitrate slurry in patients with malignant pleural effusion","volume":"69","author":"Yo SA","year":"2020","unstructured":"Yo SA, Mo EB, El AA, Ah EH, Hassan MS. Comparison between thoracoscopic pleurodesis results by talc, doxycycline poudrage, and silver nitrate slurry in patients with malignant pleural effusion. Egyptian J Chest Dis Tuberc. 2020, 69:105-11. 10.4103\/ejcdt.ejcdt_63_19","journal-title":"Egyptian J Chest Dis Tuberc"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar R","year":"2018","unstructured":"Bhatnagar R, Keenan EK, Morley AJ, et al.. Outpatient talc administration by indwelling pleural catheter for malignant effusion. N Engl J Med. 2018, 378:1313-22. 10.1056\/NEJMoa1716883","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan S","year":"2018","unstructured":"Muruganandan S, Azzopardi M, Fitzgerald DB, et al.. Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial. Lancet Respir Med. 2018, 6:671-80. 10.1016\/S2213-2600(18)30288-1","journal-title":"Lancet Respir Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.05.49","article-title":"Pleural catheters after thoracoscopic treatment of malignant pleural effusion: a randomized comparative study on quality of life","volume":"10","author":"Petrella F","year":"2018","unstructured":"Petrella F, Maisonneuve P, Borri A, et al.. Pleural catheters after thoracoscopic treatment of malignant pleural effusion: a randomized comparative study on quality of life. J Thorac Dis. 2018, 10:2999-3004. 10.21037\/jtd.2018.05.49","journal-title":"J Thorac Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyy020","article-title":"Sterilized talc pleurodesis for malignant pleural effusions: a phase II study for investigational new drug application in Japan","volume":"48","author":"Saka H","year":"2018","unstructured":"Saka H, Oki M, Kitagawa C, et al.. Sterilized talc pleurodesis for malignant pleural effusions: a phase II study for investigational new drug application in Japan. Jpn J Clin Oncol. 2018, 48:376-81. 10.1093\/jjco\/hyy020","journal-title":"Jpn J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2017.01.019","article-title":"A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14)","volume":"108","author":"Boshuizen RC","year":"2017","unstructured":"Boshuizen RC, Vd Noort V, Burgers JA, et al.. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). Lung Cancer. 2017, 108:9-14. 10.1016\/j.lungcan.2017.01.019","journal-title":"Lung Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas R","year":"2017","unstructured":"Thomas R, Fysh ET, Smith NA, et al.. Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial. JAMA. 2017, 318:1903-12. 10.1001\/jama.2017.17426","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial","volume":"195","author":"Wahidi MM","year":"2017","unstructured":"Wahidi MM, Reddy C, Yarmus L, et al.. Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP trial. Am J Respir Crit Care Med. 2017, 195:1050-7. 10.1164\/rccm.201607-1404OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.12968\/ijpn.2016.22.7.351","article-title":"A prospective study of patient-centred outcomes in the management of malignant pleural effusions","volume":"22","author":"Walker S","year":"2016","unstructured":"Walker S, Zubrinic M, Massey C, Shargall Y, B\u00e9dard E, Darling G. A prospective study of patient-centred outcomes in the management of malignant pleural effusions. Int J Palliat Nurs. 2016, 22:351-8. 10.12968\/ijpn.2016.22.7.351","journal-title":"Int J Palliat Nurs"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000440727","article-title":"Safety profile of the use of iodopovidone for pleurodesis in patients with malignant pleural effusion","volume":"90","author":"Andrade Neto JD","year":"2015","unstructured":"Andrade Neto JD, Terra RM, Teixeira RM, Pereira SV, Pego-Fernandes PM. Safety profile of the use of iodopovidone for pleurodesis in patients with malignant pleural effusion. Respiration. 2015, 90:369-75. 10.1159\/000440727","journal-title":"Respiration"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/0269216314521851","article-title":"Quality-of-Life assessment in malignant pleural effusion treated with indwelling pleural catheter: a prospective study","volume":"28","author":"Lorenzo MJ","year":"2014","unstructured":"Lorenzo MJ, Modesto M, P\u00e9rez J, et al.. Quality-of-Life assessment in malignant pleural effusion treated with indwelling pleural catheter: a prospective study. Palliat Med. 2014, 28:326-34. 10.1177\/0269216314521851","journal-title":"Palliat Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1908","article-title":"Quality-adjusted survival following treatment of malignant pleural effusions with indwelling pleural catheters","volume":"145","author":"Ost DE","year":"2014","unstructured":"Ost DE, Jimenez CA, Lei X, et al.. Quality-adjusted survival following treatment of malignant pleural effusions with indwelling pleural catheters. Chest. 2014, 145:1347-56. 10.1378\/chest.13-1908","journal-title":"Chest"},{"key":"ref26","article-title":"Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results","volume":"32","author":"Basso SM","year":"2012","unstructured":"Basso SM, Mazza F, Marzano B, Santeufemia DA, Chiara GB, Lumachi F. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results. Anticancer Res. 2012, 32:5131-4.","journal-title":"Anticancer Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies HE","year":"2012","unstructured":"Davies HE, Mishra EK, Kahan BC, et al.. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA. 2012, 307:2383-9. 10.1001\/jama.2012.5535","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2012.0102","article-title":"Optimal management of malignant pleural effusions (results of CALGB 30102)","volume":"10","author":"Demmy TL","year":"2012","unstructured":"Demmy TL, Gu L, Burkhalter JE, et al.. Optimal management of malignant pleural effusions (results of CALGB 30102). J Natl Compr Canc Netw. 2012, 10:975-82. 10.6004\/jnccn.2012.0102","journal-title":"J Natl Compr Canc Netw"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2657","article-title":"Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion","volume":"142","author":"Fysh ET","year":"2012","unstructured":"Fysh ET, Waterer GW, Kendall PA, et al.. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest. 2012, 142:394-400. 10.1378\/chest.11-2657","journal-title":"Chest"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-1679","article-title":"Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions","volume":"139","author":"Cartaxo AM","year":"2011","unstructured":"Cartaxo AM, Vargas FS, Salge JM, et al.. Improvements in the 6-min walk test and spirometry following thoracentesis for symptomatic pleural effusions. Chest. 2011, 139:1424-9. 10.1378\/chest.10-1679","journal-title":"Chest"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2010.09.005","article-title":"Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial","volume":"40","author":"Mohsen TA","year":"2011","unstructured":"Mohsen TA, Zeid AA, Meshref M, Tawfeek N, Redmond K, Ananiadou OG, Haj-Yahia S. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial. Eur J Cardiothorac Surg. 2011, 40:282-6. 10.1016\/j.ejcts.2010.09.005","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-1868","article-title":"Rapid pleurodesis for malignant pleural effusions: a pilot study","volume":"139","author":"Reddy C","year":"2011","unstructured":"Reddy C, Ernst A, Lamb C, Feller-Kopman D. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest. 2011, 139:1419-23. 10.1378\/chest.10-1868","journal-title":"Chest"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-010-1447-8","article-title":"Is silver nitrate pleurodesis for patients with malignant pleural effusion feasible and safe when performed in an outpatient setting?","volume":"18","author":"Terra RM","year":"2011","unstructured":"Terra RM, Kim SY, Pego-Fernandes PM, Teixeira LR, Vargas FS, Jatene FB. Is silver nitrate pleurodesis for patients with malignant pleural effusion feasible and safe when performed in an outpatient setting?. Ann Surg Oncol. 2011, 18:1145-50. 10.1245\/s10434-010-1447-8","journal-title":"Ann Surg Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2448","article-title":"Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?","volume":"136","author":"Terra RM","year":"2009","unstructured":"Terra RM, Junqueira JJ, Teixeira LR, Vargas FS, P\u00eago-Fernandes PM, Jatene FB. Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?. Chest. 2009, 136:361-8. 10.1378\/chest.08-2448","journal-title":"Chest"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.3.909","article-title":"Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion","volume":"127","author":"Dresler CM","year":"2005","unstructured":"Dresler CM, Olak J, Herndon JE 2nd, et al.. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005, 127:909-15. 10.1378\/chest.127.3.909","journal-title":"Chest"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.3.822","article-title":"A randomized, phase III, double-blind, placebo-controlled trial of intrapleural instillation of methylprednisolone acetate in the management of malignant pleural effusion","volume":"123","author":"North SA","year":"2003","unstructured":"North SA, Au HJ, Halls SB, Tkachuk L, Mackey JR. A randomized, phase III, double-blind, placebo-controlled trial of intrapleural instillation of methylprednisolone acetate in the management of malignant pleural effusion. Chest. 2003, 123:822-7. 10.1378\/chest.123.3.822","journal-title":"Chest"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-4975(99)01482-4","article-title":"Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter","volume":"69","author":"Putnam JB Jr","year":"2000","unstructured":"Putnam JB Jr, Walsh GL, Swisher SG, et al.. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg. 2000, 69:369-75. 10.1016\/s0003-4975(99)01482-4","journal-title":"Ann Thorac Surg"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000667","article-title":"Minimal clinically important difference for chest discomfort in patients undergoing pleural interventions","volume":"7","author":"Dahlberg GJ","year":"2020","unstructured":"Dahlberg GJ, Maldonado F, Chen H, et al.. Minimal clinically important difference for chest discomfort in patients undergoing pleural interventions. BMJ Open Respir Res. 2020, 7:2641-53. 10.1136\/bmjresp-2020-000667","journal-title":"BMJ Open Respir Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson NK","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, et al.. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993, 85:365-76. 10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"key":"ref40","article-title":"Bottomley A, on behalf of the EORTC Quality of Life Group: The EORTC QLQ-C30 scoring manual","author":"Fayers PM AN","year":"2001","unstructured":"Fayers PM AN, Bjordal K, Groenvold M, Curran D, Bottomley A. The EORTC QLQ-C30 Scoring Manual. European Organisation for Research and Treatment of Cancer, Brussels; 2001. https:\/\/www.eortc.org\/app\/uploads\/sites\/2\/2018\/02\/SCmanual.pdf."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman M","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al.. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011, 20:1727-36. 10.1007\/s11136-011-9903-x","journal-title":"Qual Life Res"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4730020305","article-title":"The RAND 36-Item Health Survey 1.0","volume":"2","author":"Hays RD","year":"1993","unstructured":"Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993, 2:217-27. 10.1002\/hec.4730020305","journal-title":"Health Econ"},{"key":"ref43","unstructured":"The World Health Organization Quality of Life (WHOQOL)-BREF, 2012 revision. (2012). https.\/\/www.who.int\/tools\/whoqol\/whoqol-bref."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)90535-5","article-title":"The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life","volume":"30A","author":"Bergman B","year":"1994","unstructured":"Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life. Eur J Cancer. 1994, 30A:635-42. 10.1016\/0959-8049(94)90535-5","journal-title":"Eur J Cancer"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2007.12.015","article-title":"Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Palliative care (FACIT-Pal) scale","volume":"37","author":"Lyons KD","year":"2009","unstructured":"Lyons KD, Bakitas M, Hegel MT, Hanscom B, Hull J, Ahles TA. Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Palliative care (FACIT-Pal) scale. J Pain Symptom Manage. 2009, 37:23-32. 10.1016\/j.jpainsymman.2007.12.015","journal-title":"J Pain Symptom Manage"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2000.0786","article-title":"Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL)","volume":"94","author":"Garrod R","year":"2000","unstructured":"Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med. 2000, 94:589-96. 10.1053\/rmed.2000.0786","journal-title":"Respir Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.3.570","article-title":"The Functional Assessment of Cancer Therapy scale: development and validation of the general measure","volume":"11","author":"Cella DF","year":"1993","unstructured":"Cella DF, Tulsky DS, Gray G, et al.. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993, 11:570-9. 10.1200\/JCO.1993.11.3.570","journal-title":"J Clin Oncol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1081\/copd-200050651","article-title":"Measurement properties and interpretability of the chronic respiratory disease questionnaire (CRQ)","volume":"2","author":"Sch\u00fcnemann HJ","year":"2005","unstructured":"Sch\u00fcnemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement properties and interpretability of the chronic respiratory disease questionnaire (CRQ). COPD. 2005, 2:81-9. 10.1081\/copd-200050651","journal-title":"COPD"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1081\/cnv-200026487","article-title":"Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS)","volume":"22","author":"Chang VT","year":"2004","unstructured":"Chang VT, Hwang SS, Kasimis B, Thaler HT. Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest. 2004, 22:526-36. 10.1081\/cnv-200026487","journal-title":"Cancer Invest"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.16840","article-title":"Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial","volume":"314","author":"Rahman NM","year":"2015","unstructured":"Rahman NM, Pepperell J, Rehal S, et al.. Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: the TIME1 randomized clinical trial. JAMA. 2015, 314:2641-53. 10.1001\/jama.2015.16840","journal-title":"JAMA"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14451","article-title":"Device assessed activity behaviours in patients with indwelling pleural catheter: a sub-study of the Australasian Malignant PLeural Effusion (AMPLE)-2 randomized trial","volume":"28","author":"Peddle-McIntyre CJ","year":"2023","unstructured":"Peddle-McIntyre CJ, Muruganandan S, McVeigh J, et al.. Device assessed activity behaviours in patients with indwelling pleural catheter: a sub-study of the Australasian Malignant PLeural Effusion (AMPLE)-2 randomized trial. Respirology. 2023, 28:561-70. 10.1111\/resp.14451","journal-title":"Respirology"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-020-01940-6","article-title":"Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials","volume":"18","author":"Wang L","year":"2020","unstructured":"Wang L, Deng H, Chen X, Li C, Yi F, Wei Y, Zhang W. Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials. World J Surg Oncol. 2020, 18:184. 10.1186\/s12957-020-01940-6","journal-title":"World J Surg Oncol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010529.pub3","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","volume":"4","author":"Dipper A","year":"2020","unstructured":"Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev. 2020, 4:CD010529. 10.1002\/14651858.CD010529.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2018-001610","article-title":"Quality of life after interventions for malignant pleural effusions: a systematic review","volume":"10","author":"Sivakumar P","year":"2020","unstructured":"Sivakumar P, Saigal A, Ahmed L. Quality of life after interventions for malignant pleural effusions: a systematic review. BMJ Support Palliat Care. 2020, 10:45-54. 10.1136\/bmjspcare-2018-001610","journal-title":"BMJ Support Palliat Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/196786-patient-reported-outcomes-in-pleural-effusions-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:16:36Z","timestamp":1707509796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/196786-patient-reported-outcomes-in-pleural-effusions-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,17]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7759\/cureus.52430","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,17]]}}}